Related Experiment Videos
Protection against thrombosis in mice lacking PAR3
Ethan J Weiss1, Justin R Hamilton, Katy E Lease
1Cardiovascular Research Institute, Department of Medicine, University of California-San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143-0130, USA.
Blood
|October 18, 2002
Summary
Reducing platelet response to thrombin by inhibiting protease-activated receptor-3 (PAR3) protects against thrombosis. This suggests PAR inhibition could be a therapeutic strategy for preventing blood clots in humans.
Area of Science:
- Hematology
- Cardiovascular Biology
- Thrombosis Research
Background:
- Protease-activated receptor-4 (PAR4) knockout ablates thrombin signaling in mouse platelets, protecting against thrombosis.
- Human platelets have two thrombin receptors, making complete ablation of thrombin signaling difficult.
- Protease-activated receptor-3 (PAR3) acts as a cofactor for PAR4, enhancing thrombin responses in mouse platelets.
Purpose of the Study:
- To investigate the role of PAR3's cofactor function in thrombin-mediated platelet signaling and thrombosis.
- To determine if partial reduction in thrombin signaling, via PAR3 deficiency, confers antithrombotic effects.
- To evaluate the therapeutic potential of PAR inhibition for thrombosis prevention.
Main Methods:
- Utilized knockout mouse models (Par3(-/-) and Par4(-/-)).
- Assessed protection against ferric chloride-induced thrombosis in mesenteric arterioles.
- Evaluated protection against thromboplastin-induced pulmonary embolism.
- Measured tail bleeding times to assess hemostasis.
Main Results:
- Par3(-/-) mice exhibited protection against mesenteric arteriolar thrombosis and pulmonary embolism.
- Protection in Par3(-/-) mice was comparable to that observed in Par4(-/-) mice.
- Both Par3(-/-) and Par4(-/-) mice showed prolonged tail bleeding times, indicating impaired hemostasis.
Conclusions:
- Partial reduction of thrombin signaling in platelets, through PAR3 deficiency, is sufficient to protect against thrombosis in vivo.
- PAR3's cofactor function is crucial for maximal thrombin responses in platelets.
- These findings highlight the importance of platelet thrombin signaling in thrombosis and suggest PAR inhibition as a potential antithrombotic strategy.